Arich Enterprise Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 08, 2022 at 08:53 pm
Share
Arich Enterprise Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 254.65 million compared to TWD 246.81 million a year ago. Revenue was TWD 241.19 million compared to TWD 228.97 million a year ago. Net income was TWD 19.97 million compared to TWD 9.76 million a year ago. Basic earnings per share from continuing operations was TWD 0.27 compared to TWD 0.13 a year ago. Diluted earnings per share from continuing operations was TWD 0.27 compared to TWD 0.13 a year ago.
For the six months, sales was TWD 533.39 million compared to TWD 493.78 million a year ago. Revenue was TWD 495.67 million compared to TWD 472.55 million a year ago. Net income was TWD 32.15 million compared to TWD 21.27 million a year ago. Basic earnings per share from continuing operations was TWD 0.43 compared to TWD 0.29 a year ago. Diluted earnings per share from continuing operations was TWD 0.43 compared to TWD 0.28 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
